Payment overview · 2025
General Payments
$24.98
1 reported records · 1 companies
Healthcare provider profile · identity verified
Vincent P Rappa, MD
Allopathic & Osteopathic Physicians|Internal Medicine · FOREST HILLS, NY · NPI 1760545883
Verified facts
What the public records show
CMS Open Payments records show Vincent P Rappa, MD received $24.98 in general payments during 2025 across 1 reported records.
Neurocrine BioSciences, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $24.98 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $24.98 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $24.98 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 845 | 86 |
| Amlodipine Besylate | Amlodipine Besylate | 637 | 95 |
| Furosemide | Furosemide | 569 | 101 |
| Atorvastatin Calcium | Atorvastatin Calcium | 535 | 99 |
| Levothyroxine Sodium | Levothyroxine Sodium | 530 | 71 |
| Metoprolol Tartrate | Metoprolol Tartrate | 528 | 74 |
| Famotidine | Famotidine | 379 | 56 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 317 | 73 |
| Gabapentin | Gabapentin | 271 | 44 |
| Losartan Potassium | Losartan Potassium | 269 | 47 |
| Potassium Chloride | Potassium Chloride | 269 | 39 |
| Mirtazapine | Mirtazapine | 261 | 38 |
| Januvia | Sitagliptin Phosphate | 244 | 20 |
| Tamsulosin Hcl | Tamsulosin Hcl | 233 | 37 |
| Escitalopram Oxalate | Escitalopram Oxalate | 232 | 32 |
| Levetiracetam | Levetiracetam | 231 | 22 |
| Metoprolol Succinate | Metoprolol Succinate | 226 | 39 |
| Xarelto | Rivaroxaban | 218 | 18 |
| Trazodone Hcl | Trazodone Hcl | 217 | 31 |
| Donepezil Hcl | Donepezil Hcl | 197 | 32 |
| Lisinopril | Lisinopril | 190 | 28 |
| Omeprazole | Omeprazole | 180 | 34 |
| Simvastatin | Simvastatin | 177 | 31 |
| Memantine Hcl | Memantine Hcl | 176 | 30 |
| Latanoprost | Latanoprost | 168 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 134 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 128 | 21 |
| Finasteride | Finasteride | 121 | 24 |
| Metformin Hcl | Metformin Hcl | 120 | 19 |
| Mupirocin | Mupirocin | 115 | 35 |
| Sodium Chloride | 0.9 % Sodium Chloride | 113 | 62 |
| Buspirone Hcl | Buspirone Hcl | 112 | 18 |
| Silver Sulfadiazine | Silver Sulfadiazine | 112 | 42 |
| Hydralazine Hcl | Hydralazine Hcl | 108 | 16 |
| Pantoprazole Sodium | Pantoprazole Sodium | 107 | 27 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 106 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 99 | 18 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 96 | 18 |
| Lactulose | Lactulose | 89 | 13 |
| Hydrochlorothiazide | Hydrochlorothiazide | 87 | 15 |
| Atenolol | Atenolol | 81 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 80 | 22 |
| Spironolactone | Spironolactone | 80 | 20 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 78 | suppressed |
| Prednisone | Prednisone | 78 | 22 |
| Divalproex Sodium | Divalproex Sodium | 77 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 76 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 75 | 14 |
| Brimonidine Tartrate | Brimonidine Tartrate | 75 | 11 |
| Warfarin Sodium | Warfarin Sodium | 74 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 73 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 72 | 11 |
| Jardiance | Empagliflozin | 67 | suppressed |
| Carvedilol | Carvedilol | 66 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 65 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 65 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 63 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 62 | 45 |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 61 | 38 |
| Admelog Solostar | Insulin Lispro | 57 | 21 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 55 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 55 | 14 |
| Ssd | Silver Sulfadiazine | 52 | 25 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 51 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 50 | suppressed |
| Entresto | Sacubitril/Valsartan | 49 | suppressed |
| Digoxin | Digoxin | 48 | suppressed |
| Hydrocortisone | Hydrocortisone | 48 | 21 |
| Santyl | Collagenase Clostridium Hist. | 46 | 14 |
| Nifedipine Er | Nifedipine | 45 | suppressed |
| Silodosin | Silodosin | 45 | suppressed |
| Lacosamide | Lacosamide | 44 | suppressed |
| Clonazepam | Clonazepam | 43 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 43 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 42 | suppressed |
| Allopurinol | Allopurinol | 41 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 40 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 39 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 38 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 38 | 28 |
| Budesonide | Budesonide | 38 | suppressed |
| Olanzapine | Olanzapine | 38 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 36 | suppressed |
| Novolog Flexpen | Insulin Aspart | 36 | suppressed |
| Pregabalin | Pregabalin | 36 | suppressed |
| Procrit | Epoetin Alfa | 36 | suppressed |
| Timolol Maleate | Timolol Maleate | 36 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 35 | 13 |
| Lorazepam | Lorazepam | 35 | suppressed |
| Nystatin | Nystatin | 35 | 16 |
| Sodium Chloride | Sodium Chloride 0.45 % | 35 | 23 |
| Meropenem | Meropenem | 34 | 22 |
| Amiodarone Hcl | Amiodarone Hcl | 33 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 33 | 26 |
| Doxycycline Hyclate | Doxycycline Hyclate | 32 | 23 |
| Enalapril Maleate | Enalapril Maleate | 32 | suppressed |
| Glipizide | Glipizide | 32 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 31 | suppressed |
| Baclofen | Baclofen | 30 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 30 | suppressed |
| Dutasteride | Dutasteride | 30 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 30 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Ezetimibe | Ezetimibe | 28 | suppressed |
| Ketoconazole | Ketoconazole | 27 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 27 | suppressed |
| Dexamethasone | Dexamethasone | 26 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 26 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 26 | 20 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 26 | suppressed |
| Calcitriol | Calcitriol | 24 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 24 | suppressed |
| Insulin Lispro | Insulin Lispro | 24 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 24 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 24 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 23 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 23 | suppressed |
| Riluzole | Riluzole | 23 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 22 | suppressed |
| Verapamil Sr | Verapamil Hcl | 22 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 21 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 21 | suppressed |
| Metronidazole | Metronidazole | 21 | suppressed |
| Rhopressa | Netarsudil Mesylate | 21 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 20 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Metronidazole | Metronidazole/Sodium Chloride | 20 | 16 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 20 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | suppressed |
| Amantadine | Amantadine Hcl | 19 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Yupelri | Revefenacin | 19 | suppressed |
| Alphagan P | Brimonidine Tartrate | 18 | suppressed |
| Anastrozole | Anastrozole | 18 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 18 | suppressed |
| Erythromycin | Erythromycin Base | 18 | suppressed |
| Scopolamine | Scopolamine | 18 | suppressed |
| Securesafe Pen Needle | Pen Needle, Diabetic, Safety | 18 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 17 | 14 |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Nystop | Nystatin | 17 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 16 | suppressed |
| Myrbetriq | Mirabegron | 16 | suppressed |
| Alogliptin | Alogliptin Benzoate | 15 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Acetylcysteine | Acetylcysteine | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 14 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 14 | suppressed |
| Cilostazol | Cilostazol | 13 | suppressed |
| Creon | Lipase/Protease/Amylase | 13 | suppressed |
| Entacapone | Entacapone | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Cyclosporine | Cyclosporine | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Galantamine Er | Galantamine Hbr | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 12 | suppressed |
| Mercaptopurine | Mercaptopurine | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Mupirocin | Mupirocin Calcium | 12 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 12 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 12 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 12 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 12 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 12 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 11 | suppressed |
| Formoterol Fumarate | Formoterol Fumarate | 11 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 11 | suppressed |
| Imatinib Mesylate | Imatinib Mesylate | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Nyamyc | Nystatin | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $24.98 · 1 records | Neurocrine BioSciences, Inc. | INGREZZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error